Anita Kaw

Anita Kaw

Auto-generated profile, based on publicly available information

Anita Kaw

University of Texas Health Science Center at Houston

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2022 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
PDF file
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
PGPujun Guan
Pujun Guan
SMSuravi Majumder
Suravi Majumder
KKKaveeta Kaw
Kaveeta Kaw
ZZZhen Zhou
Zhen Zhou
DMDianna M. Milewicz
Dianna M. Milewicz
Background: Vascular smooth muscle cells (SMCs) undergo complex phenotypic modulation with atherosclerotic plaque formation in hyperlipidemic mice, which is characterized by de-differentiation and heterogeneous increases in the expression of macrophage, fibroblast, osteogenic, and stem cell markers. An increase of cellular cholesterol in SMCs triggers similar phenotypic changes in vitro with exposure to free cholesterol due to cholesterol entering the endoplasmic reticulum, triggering endoplasmic reticulum stress and activating Perk (protein kinase RNA-like endoplasmic reticulum kinase) signaling. Methods: We generated an SMC-specific Perk knockout mouse model, induced hyperlipidemia in the mice by AAV- PCSK9 DY injection, and subjected them to a high-fat diet. We then assessed atherosclerotic plaque formation and performed single-cell transcriptomic studies using aortic tissue from these mice. Results: SMC-specific deletion of Perk reduces atherosclerotic plaque formation in male hyperlipidemic mice by 80%. Single-cell transcriptomic data identify 2 clusters of modulated SMCs in hyperlipidemic mice, one of which is absent when Perk is deleted in SMCs. The 2 modulated SMC clusters have significant overlap of transcriptional changes, but the Perk-dependent cluster uniquely shows a global decrease in the number of transcripts. SMC-specific Perk deletion also prevents migration of both contractile and modulated SMCs from the medial layer of the aorta. Conclusions: Our results indicate that hypercholesterolemia drives both Perk-dependent and Perk-independent SMC modulation and that deficiency of Perk significantly blocks atherosclerotic plaque formation.

14 May 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
AKAnita Kaw
Anita Kaw
KKKaveeta Kaw
Kaveeta Kaw
EHEllen M. Hostetler
Ellen M. Hostetler
ABAna Beleza‐Meireles
Ana Beleza‐Meireles
ASAdam Smith‐Collins
Adam Smith‐Collins
DMDianna M. Milewicz
Dianna M. Milewicz

12 October 2023 in Research Square
Verified
Preprint
Open access
PDF file
AKAnita Kaw
Anita Kaw
TWTing Wu
Ting Wu
ZSZbigniew Starosolski
Zbigniew Starosolski
ZZZhen Zhou
Zhen Zhou
APAlbert Pedroza
Albert Pedroza
DMDianna M. Milewicz
Dianna M. Milewicz
ACTA2 pathogenic variants altering arginine 179 cause childhood-onset strokes due to moyamoya disease (MMD)-like occlusion of the distal internal carotid arteries. A smooth muscle cell (SMC)-specific knock-in mouse model (Acta2SMC-R179C/+) inserted the mutation into 67% of aortic SMCs, whereas explanted SMCs were uniformly heterozygous. Acta2R179C/+ SMCs fail to fully differentiate and maintain stem cell-like features, including high glycolytic flux, and increasing oxidative respiration (OXPHOS) with nicotinamide riboside (NR) drives the mutant SMCs to differentiate and decreases migration. Acta2SMC-R179C/+ mice have intraluminal MMD-like occlusive lesions and strokes after carotid artery injury, whereas the similarly treated WT mice have no strokes and patent lumens. Treatment with NR prior to the carotid artery injury attenuates the strokes, MMD-like lumen occlusions, and aberrant vascular remodeling in the Acta2SMC-R179C/+ mice. These data highlight the role of immature SMCs in MMD-associated occlusive disease and demonstrate that altering SMC metabolism to drive quiescence of Acta2R179C/+ SMCs attenuates strokes and aberrant vascular remodeling in the Acta2SMC-R179C/+ mice.